Expand ALT Menu
ALT MENU

ALT Latest Press Releases

-- March 27, 2024 --

Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results Globe Newswire 7:00 AM

-- March 20, 2024 --

Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024 Globe Newswire 7:30 AM

-- March 7, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT Globe Newswire 4:36 PM

-- March 5, 2024 --

ROSEN, A LONGSTANDING LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT PRNewswire 5:30 PM

-- March 3, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT PRNewswire 10:15 AM

-- February 28, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT Globe Newswire 3:40 PM
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation ALT Globe Newswire 2:18 PM

-- February 26, 2024 --

Altimmune, Inc. (ALT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings Business Wire 4:00 AM

-- February 25, 2024 --

ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT PRNewswire 1:30 PM

-- February 24, 2024 --

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation ALT Globe Newswire 1:15 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT PRNewswire 10:00 AM

-- February 20, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT Globe Newswire 3:37 PM

-- February 19, 2024 --

NATIONALLY RANKED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation ALT Globe Newswire 4:53 PM

-- February 16, 2024 --

ROSEN, LEADING INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT PRNewswire 4:33 PM

-- February 15, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT PRNewswire 5:45 PM

-- February 14, 2024 --

ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation ALT Business Wire 4:39 PM

-- January 2, 2024 --

Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024 Globe Newswire 7:30 AM

-- December 5, 2023 --

Mangoceuticals ($MGRX) pioneering the future of men's health with innovative products and strategic partnerships InvestorBrandMedia 7:18 AM

-- November 30, 2023 --

Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide Globe Newswire 4:24 PM